Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study

The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of screening vary by an individual's risk of developing prostate cancer could inform decis...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	PLoS medicine Ročník 16; číslo 12; s. e1002998
Hlavní autori:	Callender, Tom, Emberton, Mark, Morris, Steve, Eeles, Ros, Kote-Jarai, Zsofia, Pharoah, Paul D. P., Pashayan, Nora
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Public Library of Science 20.12.2019 Public Library of Science (PLoS)
Predmet:	Age Aged Antigens Cancer research Cancer screening Comparative analysis Computer simulation Cost analysis Cost-Benefit Analysis Decision making Early Detection of Cancer - methods Economic aspects England Epidemiology Fatalities Genetic aspects Health aspects Health care costs Health risks Humans Incidence Life Tables Male Mass Screening - methods Mathematical models Medical economics Medical research Medical tests Medicine and Health Sciences Mental task performance Middle Aged Mortality Parameter uncertainty Population Population studies Prevention Preventive medicine Prostate cancer Prostate-specific antigen Prostate-Specific Antigen - analysis Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Quality-Adjusted Life Years Retirement benefits Risk Assessment Sensitivity analysis Social Sciences Software Task forces Thresholds Tradeoffs United Kingdom England United Kingdom United Kingdom > UK
ISSN:	1549-1676, 1549-1277, 1549-1676
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!